PALO ALTO, Calif., May 30, 2025 /PRNewswire/ -- Transcripta Bio today announced a research collaboration with Microsoft Research to accelerate the discovery of disease-gene associations using advanced ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Transcripta Bio, a platform drug development biotechnology company that is revolutionizing discovering and developing medicines at unprecedented speed, scale, and ...
The traditional drug discovery process of identifying the causal mechanism of a disease, a single molecular target, and a drug against the target is slow, expensive, and fraught with the fallout from ...
SOLVE FSHD Announces Strategic Collaboration with Transcripta Bio to Advance Drug Discovery for FSHD
VANCOUVER, British Columbia, March 25, 2025--(BUSINESS WIRE)--SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), is ...
Transcripta Bio attempts to take on rare diseases by matching older, existing drugs to newer use cases. The startup’s unusual approach could be a more cost-effective solution to drug matching. AI is ...
SOLVE FSHD Announces Strategic Collaboration with Transcripta Bio to Advance Drug Discovery for FSHD
SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), is pleased to announce a strategic collaboration with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback